1,2,3,4,5-pentamethyl-pyrrolidine | 102450-05-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 英文名称: 1,2,3,4,5-pentamethyl-pyrrolidine
• 英文别名: 1,2,3,4,5-Pentamethyl-pyrrolidin；1,2,3,4,5-Pentamethylpyrrolidine
• CAS: 102450-05-5
• 化学式: C₉H₁₉N
• 分子量: 141.257
• InChiKey: IIRRFUZYXRBHHF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  2,3,4-三甲基-1H-吡咯 在 甲醇 、 聚合甲醛 、 镍 、 二乙胺 作用下， 190.0 ℃ 、9.81 MPa 条件下， 生成 1,2,3,4,5-pentamethyl-pyrrolidine
  参考文献：
  名称：

  Treibs; Zinsmeister, Chemische Berichte, 1957, vol. 90, p. 87,92

  摘要：

  DOI：

文献信息

• POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICALLY ANISOTROPIC SUBSTANCE
  申请人：ZEON CORPORATION

  公开号：US20150274647A1

  公开（公告）日：2015-10-01

  The present invention relates to: a polymerizable compound represented by a formula (I); a polymerizable composition comprising the polymerizable compound and an initiator; a polymer obtained by polymerizing the polymerizable compound or the polymerizable composition; and an optically anisotropic article comprising the polymer [in the formula, Y 1 to Y 8 are a chemical single bond, —O—, —O—C(═O)—, —C(═O)—O—, or the like; G 1 and G 2 are a divalent aliphatic group having 1 to 20 carbon atoms, or the like; Z 1 and Z 2 are an alkenyl group having 2 to 10 carbon atoms, or the like; A 1 is a tetravalent aromatic group, or the like; A 2 and A 3 are a divalent alicyclic hydrocarbon group having 3 to 30 carbon atoms, or the like; A 4 and A 5 are a divalent aromatic group having 4 to 30 carbon atoms, or the like; A x1 and A x2 are an organic group having 2 to 30 carbon atoms that includes an aromatic ring, or the like; A y1 and A y2 are a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or the like; Q 1 and Q 2 are a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or the like; and m and n are 0 or 1]. According to the present invention, a polymerizable compound, a polymerizable composition, and a polymer that have a practical low melting point, exhibit excellent solubility in a general-purpose solvent, can be produced at low cost, and can produce an optical film that achieves uniform conversion of polarized light over a wide wavelength band, and also provide an optically anisotropic article.

  本发明涉及：由式(I)表示的可聚合化合物；包括所述可聚合化合物和引发剂的可聚合组合物；通过聚合所述可聚合化合物或可聚合组合物得到的聚合物；以及包括所述聚合物的光学各向异性物品[在该式中，Y1至Y8为化学单键，—O—，—O—C(═O)—，—C(═O)—O—等；G1和G2为具有1至20个碳原子的二价脂肪族基等；Z1和Z2为具有2至10个碳原子的烯基基团等；A1为四价芳香族基等；A2和A3为具有3至30个碳原子的二价脂环烃基等；A4和A5为具有4至30个碳原子的二价芳香族基等；Ax1和Ax2为包括芳香环的具有2至30个碳原子的有机基团等；Ay1和Ay2为氢原子、具有1至6个碳原子的烷基基团等；Q1和Q2为氢原子、具有1至6个碳原子的烷基基团等；m和n为0或1]。根据本发明，可以制备具有实用低熔点、在通用溶剂中具有优异溶解性、成本低廉的可聚合化合物、可聚合组合物和聚合物，并且可以生产出在宽波长范围内实现偏振光均匀转换的光学薄膜，同时提供光学各向异性物品。
• Substituted Benzo-Pyrimido-Tetrazolo-Diazepine Compounds
  申请人：Yang Rui-Yang

  公开号：US20110166127A1

  公开（公告）日：2011-07-07

  The present invention relates to substituted benzo-pyrimido-tetrazolo-diazepine compounds and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing substituted benzo-pyrimido-tetrazolo-diazepine compounds and methods of treating cell proliferative disorders, such as cancer, by administering these compounds and pharmaceutical compositions to subjects in need thereof.

  本发明涉及替代苯并嘧啶-四氮唑-二氮杂环庚烷化合物及其合成方法。本发明还涉及含有替代苯并嘧啶-四氮唑-二氮杂环庚烷化合物的药物组合物，以及通过向需要的受试者投予这些化合物和药物组合物来治疗细胞增殖性疾病，如癌症的方法。
• Medicinal Composition Containing Diabeted Remedy
  申请人：Izumi Masanori

  公开号：US20080039367A1

  公开（公告）日：2008-02-14

  A pharmaceutical composition effective for the prophylaxis and treatment of diabetes is provided. This pharmaceutical composition comprises the combination of an α-amylase inhibitor selected from a compound represented by the following general formula (I): [wherein A represents, for example, a cyclic group, etc. R 1 and R 2 represent an alkyl group, hydroxymethyl group, etc., and n represents 1 or 2], or a pharmacologically acceptable salt or ester thereof, and at least one type of drug selected from an insulin sensitizer, an insulin secretagogue, a biguanide drug, an insulin preparation and a DPP-IV inhibitor.

  提供一种用于预防和治疗糖尿病的药物组合物。该药物组合物包括以下通用式（I）所表示的化合物中选择的α-淀粉酶抑制剂：[其中A代表环状基团等，R1和R2代表烷基、羟甲基基团等，n代表1或2]，或其药理学上可接受的盐或酯，以及选择自胰岛素增敏剂、胰岛素分泌促进剂、双胍类药物、胰岛素制剂和DPP-IV抑制剂中的至少一种药物。
• Oligosaccharide Derivative
  申请人：Honda Takeshi

  公开号：US20080194495A1

  公开（公告）日：2008-08-14

  Compounds having the formula (I): wherein A represents a group such as a cyclic group, R 1 and R 2 represent groups such as alkyl groups or hydroxymethyl groups, and n represents 1 or 2, or pharmacologically acceptable salts thereof or pharmacologically acceptable esters thereof have superior activity and stability, and are useful for the treatment and/or prevention of diabetes mellitus, or the like.

  具有式(I)的化合物：其中A表示环状基团，R1和R2表示烷基或羟甲基等基团，n表示1或2，或其药学上可接受的盐或酯，在活性和稳定性方面具有优越性，可用于治疗和/或预防糖尿病等疾病。
• The Reactions of Hydrogen with Derivatives of Pyrrole.¹ II
  作者：James L. Rainey、Homer. Adkins

  DOI：10.1021/ja01874a029

  日期：1939.5